Breeze Holdings Acquisition Corp.: Nasdaq/NYSE listing notice — Breeze Holdings gets OTCQX delisting notice; merger with YD Biopharma planned by June 13

Breeze Holdings Acquisition Corp.

Received OTCQX non-compliance notice on March 17, 2025; cure deadline June 13, 2025.
Must meet net tangible assets ($2M if 3+ yrs or $5M if less), avg revenue $6M, or bid price $5/share.
Pursuing business combination with YD Biopharma Limited expected to close before June 13, 2025.
Combined company required to list on NASDAQ Capital Markets at closing.
If not cured, common stock BRZH and warrants BRZHW will be moved from OTCQX.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Breeze Holdings Acquisition Corp. received a otc noncompliance notice notice regarding other.

Exchange: otc
Notice: noncompliance notice

Exact text from the filing

March 17, 2025, Breeze Holdings Acquisition Corp. (the “Company”) received a notice from the Issuer Compliance Department of the OTC Markets Group stating that the Company is no longer in compliance with Section 2 of the Requirements for Continued Qualification of the OTCQX Rules for U.S. Companies, which requires compliance with Section 1.1(A) of the OTCQX Eligibility Criteria, requiring the Company to have (1) net tangible assets of $2,000,000, if the Company has been in continuous operation for at least three years, or $5,000,000, if the Company has been in continuous operation for less tha

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001213900-25-024825

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.